Dr. Darryl Inaba is Director of Clinical and Behavioral Health Services for the Addictions Recovery Center and Director of Research and Education of CNS Productions in Medford, Oregon. He is an associate Clinical Professor at the University of California in San Francisco, CA., Special Consultant, Instructor, at the University of Utah School on Alcohol and Other Drug Dependencies in Salt Lake City, UT and a Lifetime Fellow at Haight Ashbury Free Clinics, Inc., in San Francisco, CA. Dr. Inaba has authored several papers, award winning educational films and is co-author of Uppers, Downers, All Arounders a text on addiction and related disorders that is used in more than 400 colleges and universities. He has been honored with over 90 individual awards for his work in the areas of prevention and treatment of substance abuse problems. In March 2015, RecoveryView.com interviewed Dr. Inaba on what is the current knowledge of marijuana’s effects and mechanisms of action in the human body.
Suzanne Jessee is the creator of Neurogenesis Meditative Therapy (NMT), a new clinical system that incorporates current knowledge of Cognitive Behavioral Therapy as well as mindfulness practices. Scientific advances that demonstrate how thoughts and meditations can affect the regeneration of neuronal pathways have directly informed Jessee’s invention of this new therapeutic style.
Addiction: Conditioning the brain for reward
It is estimated that there are 1.7 million heroin and 3 to 4 million prescription opiate addicts in America. Recent data informs us that in this current era of opiate abuse more people are dying from prescription drug overdoses including opiates than are dying from highway accidents. To better understand what we in the treatment and recovery field are facing, it is useful to consider the science of pain and reward.
Prescription drug abuse, rampant among all demographics, is also affecting the medical community. A recent review indicates that more than one hundred thousand medical professionals—doctors, nurses, technicians, and aides—misuse or are addicted to medications that clearly affect their performance in the workplace.
A new alcohol vaccine being developed in Chile by Dr. Juan Asenjo is in Stage 2 clinical trials. The vaccine builds on what happens naturally in certain people when they drink alcohol.